Karli Griffeth
Ophthalmology · Roanoke, VANPI 1073888244
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.3%), food and beverage and charitable contributions — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Glaukos Corporation at 52.7% of the total. Reporting peaked in 2024 at $3,176 and has fallen 92.6% since, to $235 in 2025.
Across 66 payments — averaging $77.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$3K
- Alcon$1K
- Microsurgical Technology, Inc.$349
- AbbVie$206
- NEW World Medical,inc.$133
- Johnson & Johnson Surgical Vision, Inc.$123
- plus $561 from 8 others
Across 106 payments — averaging $556.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$59K
What the payments were for
- Speaking & faculty fees$2,67952%
- Food & beverage$2,09341%
- Charitable contribution$3497%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 3 | $2,700 |
| Alcon | 34 | $1,048 |
| Microsurgical Technology, Inc. | 1 | $349 |
| AbbVie | 5 | $206 |
| NEW World Medical,inc. | 1 | $133 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $123 |
| Bausch & Lomb Americas Inc. | 1 | $116 |
| Rxsight Inc | 2 | $111 |
| Ocular Therapeutix, Inc. | 5 | $99 |
| Rayner Intraocular Lenses Limited | 2 | $65 |
| Harrow Eye, LLC | 3 | $60 |
| Amgen(2 entities) | 4 | $60 |
| Novartis | 2 | $33 |
| Omeros Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,121 in reported general payments places this provider in the 85th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 15 | $9,467 |
| RestasisCyclosporine | 11 | $8,846 |
| Prednisolone Acetate | 157 | $7,297 |
| Cyclosporine | 11 | $5,437 |
| Ketorolac Tromethamine | 150 | $3,530 |
| Ofloxacin | 135 | $2,293 |
| Latanoprost | 139 | $1,288 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 12 | $1,249 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 41 | $715 |
| Dorzolamide Hcl | 11 | $223 |
| ErythromycinErythromycin Base | 13 | $177 |
| Timolol Maleate | 18 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis | $206 | $18,31326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 509 ophthalmology providers in Virginia.
Other ophthalmology in Roanoke
- Frank CotterRoanoke$15K
- Tad SchoedelRoanoke$12K
- Jonathan TillRoanoke$9K
- William ThompsonRoanoke$9K
- Bryan StrelowRoanoke$7K
- Ethnie JonesRichmond$2M
- Elizabeth Yeu-LinNorfolk$1.7M
- John SheppardNorfolk$1.1M
- Constance OkekeNorfolk$800K
- Marc OdrichCharlottesville$497K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.